21,344 research outputs found
GenomeVIP: A cloud platform for genomic variant discovery and interpretation
Identifying genomic variants is a fundamental first step toward the understanding of the role of inherited and acquired variation in disease. The accelerating growth in the corpus of sequencing data that underpins such analysis is making the data-download bottleneck more evident, placing substantial burdens on the research community to keep pace. As a result, the search for alternative approaches to the traditional “download and analyze” paradigm on local computing resources has led to a rapidly growing demand for cloud-computing solutions for genomics analysis. Here, we introduce the Genome Variant Investigation Platform (GenomeVIP), an open-source framework for performing genomics variant discovery and annotation using cloud- or local high-performance computing infrastructure. GenomeVIP orchestrates the analysis of whole-genome and exome sequence data using a set of robust and popular task-specific tools, including VarScan, GATK, Pindel, BreakDancer, Strelka, and Genome STRiP, through a web interface. GenomeVIP has been used for genomic analysis in large-data projects such as the TCGA PanCanAtlas and in other projects, such as the ICGC Pilots, CPTAC, ICGC-TCGA DREAM Challenges, and the 1000 Genomes SV Project. Here, we demonstrate GenomeVIP's ability to provide high-confidence annotated somatic, germline, and de novo variants of potential biological significance using publicly available data sets.</jats:p
Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space?
The organization and mining of malaria genomic and post-genomic data is
highly motivated by the necessity to predict and characterize new biological
targets and new drugs. Biological targets are sought in a biological space
designed from the genomic data from Plasmodium falciparum, but using also the
millions of genomic data from other species. Drug candidates are sought in a
chemical space containing the millions of small molecules stored in public and
private chemolibraries. Data management should therefore be as reliable and
versatile as possible. In this context, we examined five aspects of the
organization and mining of malaria genomic and post-genomic data: 1) the
comparison of protein sequences including compositionally atypical malaria
sequences, 2) the high throughput reconstruction of molecular phylogenies, 3)
the representation of biological processes particularly metabolic pathways, 4)
the versatile methods to integrate genomic data, biological representations and
functional profiling obtained from X-omic experiments after drug treatments and
5) the determination and prediction of protein structures and their molecular
docking with drug candidate structures. Progresses toward a grid-enabled
chemogenomic knowledge space are discussed.Comment: 43 pages, 4 figures, to appear in Malaria Journa
Systematizing Genome Privacy Research: A Privacy-Enhancing Technologies Perspective
Rapid advances in human genomics are enabling researchers to gain a better
understanding of the role of the genome in our health and well-being,
stimulating hope for more effective and cost efficient healthcare. However,
this also prompts a number of security and privacy concerns stemming from the
distinctive characteristics of genomic data. To address them, a new research
community has emerged and produced a large number of publications and
initiatives.
In this paper, we rely on a structured methodology to contextualize and
provide a critical analysis of the current knowledge on privacy-enhancing
technologies used for testing, storing, and sharing genomic data, using a
representative sample of the work published in the past decade. We identify and
discuss limitations, technical challenges, and issues faced by the community,
focusing in particular on those that are inherently tied to the nature of the
problem and are harder for the community alone to address. Finally, we report
on the importance and difficulty of the identified challenges based on an
online survey of genome data privacy expertsComment: To appear in the Proceedings on Privacy Enhancing Technologies
(PoPETs), Vol. 2019, Issue
Privacy in the Genomic Era
Genome sequencing technology has advanced at a rapid pace and it is now
possible to generate highly-detailed genotypes inexpensively. The collection
and analysis of such data has the potential to support various applications,
including personalized medical services. While the benefits of the genomics
revolution are trumpeted by the biomedical community, the increased
availability of such data has major implications for personal privacy; notably
because the genome has certain essential features, which include (but are not
limited to) (i) an association with traits and certain diseases, (ii)
identification capability (e.g., forensics), and (iii) revelation of family
relationships. Moreover, direct-to-consumer DNA testing increases the
likelihood that genome data will be made available in less regulated
environments, such as the Internet and for-profit companies. The problem of
genome data privacy thus resides at the crossroads of computer science,
medicine, and public policy. While the computer scientists have addressed data
privacy for various data types, there has been less attention dedicated to
genomic data. Thus, the goal of this paper is to provide a systematization of
knowledge for the computer science community. In doing so, we address some of
the (sometimes erroneous) beliefs of this field and we report on a survey we
conducted about genome data privacy with biomedical specialists. Then, after
characterizing the genome privacy problem, we review the state-of-the-art
regarding privacy attacks on genomic data and strategies for mitigating such
attacks, as well as contextualizing these attacks from the perspective of
medicine and public policy. This paper concludes with an enumeration of the
challenges for genome data privacy and presents a framework to systematize the
analysis of threats and the design of countermeasures as the field moves
forward
No wisdom in the crowd: genome annotation at the time of big data - current status and future prospects
Science and engineering rely on the accumulation
and dissemination of knowledge to make discoveries
and create new designs. Discovery-driven genome
research rests on knowledge passed on via gene
annotations. In response to the deluge of sequencing
big data, standard annotation practice employs automated
procedures that rely on majority rules. We
argue this hinders progress through the generation
and propagation of errors, leading investigators into
blind alleys. More subtly, this inductive process discourages
the discovery of novelty, which remains
essential in biological research and reflects the nature
of biology itself. Annotation systems, rather than
being repositories of facts, should be tools that support
multiple modes of inference. By combining
deduction, induction and abduction, investigators can
generate hypotheses when accurate knowledge is
extracted from model databases. A key stance is to
depart from ‘the sequence tells the structure tells the
function’ fallacy, placing function first. We illustrate
our approach with examples of critical or unexpected
pathways, using MicroScope to demonstrate how
tools can be implemented following the principles we
advocate. We end with a challenge to the reader
- …